○鈴木 貴人1, 乾 直輝1,2, 田中 和樹3, 井上 裕介1, 柄山 正人1,4, 安井 秀樹1, 穗積 宏尚1, 鈴木 勇三1, 古橋 一樹1, 藤澤 朋幸1, 松浦 駿3, 西本 幸司5, 松井 隆6, 朝田 和博7, 橋本 大8, 藤井 雅人9, 丹羽 充10, 上原 正裕11, 榎本 紀之1, 須田 隆文1 (1.浜松医科大学第二内科, 2.浜松医科大学臨床薬理学, 3.藤枝市立総合病院, 4.浜松医科大学臨床腫瘍学, 5.磐田市立総合病院, 6.聖隷三方原病院, 7.静岡県立総合病院, 8.聖隷浜松病院, 9.静岡市立静岡病院, 10.浜松医療センター, 11.島田市立総合医療センター)
Session information
Presidential Session
Presidential Session
Sat. Nov 2, 2024 2:50 PM - 4:50 PM 第1会場 (パシフィコ横浜ノース 1階 G7+G8)
座長:大江 裕一郎(国立がん研究センター中央病院副院長/呼吸器内科長), 髙橋 和久(順天堂大学大学院医学研究科呼吸器内科学)
○後藤 功一 (国立がん研究センター東病院呼吸器内科)
○Yoshitaka Zenke1, Isamu Okamoto2, Yuichiro Ohe3, Koichi Azuma4, Kyoichi Okishio5, Hirokazu Ogino6, Yoshitsugu Horio7, Satoshi Oizumi8, Manabu Hayama9, Masatoshi Sugeno10, Masaya Harada9, Yuka Olivo11, Haiyi Jiang12, Suresh Senan13 (1.National Cancer Center Hospital East, Kashiwa, Japan, 2.Kyushu University Hospital, Fukuoka, Japan, 3.National Cancer Center Hospital, Tokyo, Japan, 4.Kurume University Hospital, Kurume, Japan, 5.National Hospital Organization Kinki-chuo Chest Medical Center, Sakai, Japan, 6.Tokushima University Hospital, Tokushima, Japan, 7.Aichi Cancer Center Hospital, Nagoya, Japan, 8.Hokkaido Cancer Center, Sapporo, Japan, 9.AstraZeneca K.K., Minato-ku, Tokyo, Japan, 10.AstraZeneca K.K., Kita-ku, Osaka, Japan, 11.AstraZeneca, New York, NY, USA, 12.AstraZeneca, Gaithersburg, MD, USA, 13.Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands)
○岡本 勇 (九州大学大学院医学研究院呼吸器内科学分野)
○Fumihiro Tanaka1, Yasutaka Watanabe2, Shunichi Sugawara3, Jiro Okami4, Satoshi Muto5, Morihito Okada6, Yoshitsugu Horio7, Masahiro Tsuboi8, Yuki Sato9, Kazuya Takamochi10, Hidehito Horinouchi11, Yuichi Tambo12, Masahiro Seike13, Kyoichi Okishio14, Cinthya Coronado Erdmann15, Padma Sathyanarayana15, Stephanie Meadows Shropshire15, Hiroyuki Ito16 (1.University Of Occupational And Environmental Health Hospital, Kitakyushu, Japan, 2.Saitama Cancer Center, Saitama, Japan, 3.Sendai Kousei Hospital, Sendai, Japan, 4.Osaka International Cancer Institute, Osaka, Japan, 5.Fukushima Medical University Hospital, Fukushima, Japan, 6.Hiroshima University Hospital, Hiroshima, Japan, 7.Aichi Cancer Center Hospital, Nagoya, Japan, 8.National Cancer Center Hospital East, Kashiwa, Japan, 9.Kobe City Medical Center General Hospital, Kobe, Japan, 10.Juntendo University Hospital, Tokyo, Japan, 11.National Cancer Center Hospital, Kashiwa, Japan, 12.Kanazawa University Hospital, Kanazawa, Japan, 13.Nippon Medical School Hospital, Tokyo, Japan, 14.National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, Japan, 15.Bristol Myers Squibb, Princeton, NJ, USA, 16.Kanagawa Cancer Center, Yokohama, Japan)
○Daniel S W Tan (National Cancer Centre Singapore)
○Terufumi Kato1, Toshiaki Takahashi2, Koichi Goto3, Takayuki Takahama4, Satoshi Oizumi5, Shunichi Sugawara6, Ellie Grainger7, Azura Evans7, Toshiaki Ozaki8, Tetsu Matsubara9, Kota Suzuki9, Takako Inoue10 (1.Department of Thoracic Oncology, Kanagawa Cancer Center, Yokohama, Japan, 2.Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan, 3.Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan, 4.Department of Medical Oncology, Kindai University Hospital, Osaka, Japan, 5.Department of Respiratory Medicine, NHO Hokkaido Cancer Center, Sapporo, Japan, 6.Department of Pulmonary Medicine, Sendai Kousei Hospital, Sendai, Japan, 7.Late-stage Development, Oncology R&D, AstraZeneca, Cambridge, UK, 8.Biometrics, Data Science & Innovation, R&D, AstraZeneca, Osaka, Japan, 9.Late Development Oncology TA Division, R&D, AstraZeneca, Tokyo, Japan, 10.Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan)
○Keunchil Park (Department of Thoracic/Head&Neck Medical Oncology, UT MD Anderson Cancer Center)